Placebo for ABBV-142 clinical trials

A Phase 2a Multicenter Platform Study of Investigational Products for the Treatment of Adult Subjects with Idiopathic Pulmonary Fibrosis

This study is looking into new treatments for Idiopathic Pulmonary Fibrosis (IPF), a serious lung condition. Researchers will compare a new medicine with a dummy treatment to see if it can improve lung function over 24 weeks. It's for adults with IPF.